For SSc-ILD patients, we observed a positive correlation between TGFB2 gene expression and FEV1 (% predicted), the lower the gene expression, the lower the FEV1 (r = 0.40, p = 0.04, Table 2). The gene discussed is TGFB2; the disease is systemic sclerosis.